Angiotensin II Kit CLIA
-
- Antigène Voir toutes Angiotensin II (Ang II) Kits CLIA
- Angiotensin II (Ang II)
-
Reactivité
- Rat
- Méthode de détection
- Chemiluminescent
- Type de méthode
- Competition ELISA
- Gamme de detection
- 24.69 pg/mL - 2000 pg/mL
- Seuil minimal de détection
- 24.69 pg/mL
- Application
- ELISA
- Fonction
- Rat Angiotensin II CLIA Kit is a Competitive CLIA Kit for use with Serum, plasma, tissue homogenates, cell lysates, cell culture supernates and other biological fluids.
- Type d'échantillon
- Cell Culture Supernatant, Cell Lysate, Plasma, Serum, Tissue Homogenate
- Analytical Method
- Quantitative
- Sensibilité
- < 9.22 pg/mL
- Featured
- Discover our best selling Ang II Kit ELISA
- Top Product
- Discover our top product Ang II Kit ELISA
-
-
- Indications d'application
-
Stability: The stability of the kit is determined by the rate of activity loss. The loss rate is less than 5 % within the expiration date under appropriate storage conditions. To minimize performance fluctuations, operation procedures and lab conditions should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same user throughout.
Recommended dilutions: Optimal dilutions/concentrations should be determined by the end user.
Standard Form: Lyophilized
- Plaque
- Pre-coated
- Restrictions
- For Research Use only
-
- Stock
- 4 °C/-20 °C
- Stockage commentaire
- Upon receipt, store the kit according to the storage instruction in the kit's manual.
- Date de péremption
- 6 months
-
- Antigène Voir toutes Angiotensin II (Ang II) Kits CLIA
- Angiotensin II (Ang II)
- Autre désignation
- Angiotensin II (Ang II Produits)
- Synonymes
- ANHU Kit CLIA, SERPINA8 Kit CLIA, ANRT Kit CLIA, Ang Kit CLIA, AngII Kit CLIA, PAT Kit CLIA, AI265500 Kit CLIA, AngI Kit CLIA, Aogen Kit CLIA, Serpina8 Kit CLIA, angiotensinogen Kit CLIA, angiotensinogen (serpin peptidase inhibitor, clade A, member 8) Kit CLIA, AGT Kit CLIA, Agt Kit CLIA
- Pathways
- Signalistation JAK/STAT, ACE Inhibitor Pathway, EGFR Signaling Pathway, Peptide Hormone Metabolism, Regulation of Systemic Arterial Blood Pressure by Hormones, Regulation of Lipid Metabolism by PPARalpha, Protein targeting to Nucleus, Feeding Behaviour, Regulation of long-term Neuronal Synaptic Plasticity
-